Related Experiment Videos
Insights
Doxazosin (Cardura) effectively treats prostate adenoma symptoms, improving urination without side effects. This study suggests it
Area of Science:
- Urology
- Pharmacology
Background:
- Benign prostatic hyperplasia (BPH) is a common condition in aging men.
- Non-surgical treatment options are sought to manage BPH symptoms.
Purpose of the Study:
- To evaluate the efficacy and safety of doxazosin (Cardura) for treating prostate adenoma.
- To assess doxazosin as a non-surgical alternative for BPH management.
Main Methods:
- Analysis of treatment in 20 patients with prostate adenoma.
- Administration of selective alpha 1-adrenoblocker doxazosin (Cardura).
- Comparison with placebo effects.
Main Results:
- Doxazosin demonstrated greater efficacy than placebo.
- Significant reduction in BPH symptoms observed.
- Accelerated rate of urination noted.
- No unfavorable side effects, including no drop in blood pressure or sexual dysfunction.
Conclusions:
- Doxazosin (Cardura) is an effective and well-tolerated treatment for prostate adenoma.
- Daily single-administration of doxazosin is satisfactory.
- Cardura presents a valuable non-surgical treatment option for prostate adenoma.
Abstract:
The author submits analysis of treatment of 20 patients with adenoma of the prostate gland with the selective alpha 1-adrenoblocker doxazosin (Cardura, Pfizer, USA). The above drug was found to be more efficacious than placebo, as evidenced by reduction of disease symptoms and acceleration of rate of urination. There were no unfavourable side effects, drop of blood pressure or worsening of the sexual function. Doxazosin on a single-administration basis daily was also found to be a satisfactory and worth-while exercise. The results obtained suggest usefulness of Cardura as a non-surgical alternative treatment option for adenoma of the prostate gland.